Mental disease, existence of diagnostic, use of psychotropic medication. differences by autonomous communities under the national health survey 2006;Morbilidad psíquica, existencia de diagnóstico y consumo de psicofármacos. diferencias por comunidades autónomas según la encuesta nacional de salud de 2006

Revista Espanola de Salud Publica

Volumn 84, Issue 1, 2010, Pages 29-41

  Ricci Cabello, Ignacio ^a,b   Ruiz Pérez, Isabel ^a,b   Plazaola Castaño, Juncal ^a,b   Montero Piñar, Isabel ^a,c  

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^b ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Diagnosis; Health care surveys; Health services accessibility; Mental health; Prevalence; Small area analysis; Therapeutics

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HUMAN; MALE; MENTAL DISEASE; MENTAL STRESS; MIDDLE AGED; PREVALENCE; QUESTIONNAIRE; SOCIAL SUPPORT; SOCIOECONOMICS; SPAIN; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SPAIN; STRESS, PSYCHOLOGICAL;

EID: 77951200766     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ. 2000; 78:413-26.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al. Lifetime and 12- month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19.
3. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998; 33:587-95. (Pubitemid 28528860)
4. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003; 289:3095-105.
5. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264:2511-8.
6. Kessler RC, Gruber M, Hettema JM, Hwang I, Sampson N, Yonkers KA. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up. Psychol Med. 2008; 38:365-74.
7. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. Suppl 2004; 420:21-7.
8. Vazquez Barquero JL, Munox PE, Madoz J, V. The influence of the process of urbanization on the prevalence of neurosis. A community survey. Acta Psychiatr Scand. 1982; 65:161-70.
9. Vazquez Barquero JL, Díez Manrique JF, Peña C, Almada J, Saramiego C. A community mental health survey in Cantabria, a general description of morbidity. Psychol Med. 1987; 17:227-41.
10. Herrera R, Gispert R, Spagnolo E, Autonell J. Estudio epidemiológico en salud mental de la comarca del Baix Llobregat (Barcelona). InformPsiquiatr. 1990; 120:111-31.
11. Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001; 179:308-16.
12. Vazquez C, Munoz M, Sanz J. Lifetime and 12- month prevalence of DSM-III-R mental disorders among the homeless in Madrid: a European study using the CIDI. Acta Psychiatr Scand. 1997; 95:523-30.
13. Roca-Bennasar M, Gili-Planas M, Ferrer-Perez V, Bernardo-Arroyo M. Mental disorders and medical conditions. A community study in a small island in Spain. J Psychosom Res. 2001; 50:39-44.
14. Haro J, Palacína C, Vilagut G, Martínez M, Bernal M. Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeDEspaña. Med Clin (Barc). 2006; 126:445-51.
15. Alonso J, Angermeyer M.C, Brugha T.S, Bryson H, Girolamo G, Graaf R. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004; 109:47-54.
16. Codony M, Alonso J, Almansa J, Vilagut G, Domingo A, Pinto-Meza A et al. Uso de fármacos psicotrópicos en España. Resultados del studio ESEMeD-España. Actas Esp Psiquiatr. 2007; 35:29-36.
17. a ed. Córdoba: Universidad de Córdoba,1998.
18. Arber S. Comparing inequalities in women's and men's health: Britain in the 1990s. Soc Sci Med. 1997; 44:773-87.
19. Ministerio de Sanidad y Política Social. Encuesta Nacional de Salud [archivo electrónico] 2006 [consultado 15-01-2010]: Disponible en: http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/encuesta2006.htm
20. Lobo A, Muñoz PE. Versiones en lengua española validadas. En: Goldberg D., Williams P., editors. Cuestionario de Salud General GHQ (General Health Questionnaire). Guía para el usuario de las distintas versiones. Barcelona: Masson, 1996.
21. Bellón JA, Lardelli P., Delgado A, de Dios J. Validez y fiabilidad del cuestionario de Apoyo Social funcional de Duke-UNC-11. Aten Primaria. 1996; 18:153-63.
22. Montero I, Aparicio D, Gomez-Beneyto M, Moreno-Kustner B, Reneses B, Usall J et al. Género y salud mental en un mundo cambiante Gac Sanit. 2004; 18:175-81.
23. Brugha TS, Bebbington PE, Jenkins R, Meltzer H, Taub NA, Janas M et al. Cross validation of a general population survey diagnostic interview: a comparison of CIS-R with SCAN ICD-10 diagnostic categories Psychol Med. 1999; 29:1029-42.
24. Kessler RC, Little RJ, Groves RM. Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiol Rev. 1995; 17:192-204. 25.
25. Mateos R, Rodríguez-López A. Epidemiología de las Demencias: Perspectivas metodológicas y datos de prevalencia. Jano. 1989; 3:21-8.
26. Rajmil L, Gispert MR, Roset GM, Munoz Rodriguez PE, Segura BA. Prevalencia de trastornos mentales en la población general de Cataluña. Gac Sanit. 1998; 12:153-9.
27. Roca M, Gili M, Ferrer V, Bernardo M, Montano JJ, Salva JJ et al. Mental disorders on the island of Formentera: prevalence in general population using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Soc Psychiatry Psychiatr Epidemiol. 1999; 34:410-5.
28. Fones CS, Kua EH, Ng TP, Ko SM. Studying the mental health of a nation: a preliminary report on a population survey in Singapore. Singapore Med J. 1998; 39:251-5.
29. Noorbala AA, Bagheri Yazdi SA, Yasamy MT, Mohammad K. Mental health survey of the adult population in Iran. Br J Psychiatry. 2004; 184:70-3.
30. Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry. 2000; 34:197-205.
31. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry. 2001; 158:1091-8.
32. San Gil Martín J. Urgencias Psiquiátricas y Condiciones Meteorológicas en la Isla de Tenerife [tesis doctoral]. Tenerife (ES): Universidad La Laguna.: 1986.
33. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004; 420:55-64.
34. Corrigan P. How stigma interferes with mental health care. Am Psychol. 2004; 59:614-25.
35. Leskela U, Rytsala H, Komulainen E, Melartin T, Sokero P, Lestela-Mielonen P et al. The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptoms. Psychol Med. 2006; 36:779-88